IL-1 Immune Pathway Identified as Critical Defense Against Fatal Candida albicans Infections
核心洞察
A King's College London study published in Nature Microbiology identifies the IL-1 (搜索) immune pathway as critical in preventing Candida albicans (搜索) from spreading and causing fatal disease.
Mice genetically modified to lack IL-1 (搜索) developed severe, fatal infection when exposed to Candida albicans (搜索), confirming IL-1's protective role.
Fungal infections kill more than 2.5 million people annually, with Candida albicans (搜索) alone responsible for almost one million deaths each year.
A newly discovered immune pathway may explain why a normally harmless fungus turns deadly in certain patients with weakened immune systems, offering a potential route to identify at-risk individuals and develop targeted therapies. The King's College London study, published in Nature Microbiology, identifies the IL-1 (搜索) immune pathway as a critical early defense that prevents Candida albicans (搜索) from escaping its natural location in the mouth and gut and spreading throughout the body.
Fungal infections kill more than 2.5 million people each year, with Candida albicans (搜索) alone killing almost a million. Despite this burden, researchers have known little about why fungi escape their natural niche and cause life-threatening disease in around 10% of patients who have a weakened immune system. The new findings provide the first potential clue as to why only certain immunocompromised patients, including those undergoing chemotherapy or living with HIV, are at risk of life-threatening Candida albicans infections.
The IL-1 Pathway as a Protective Barrier
The scientists focused on IL-1 (搜索), a signal produced by the immune system to trigger symptoms that fight off infection. Mice genetically modified not to produce IL-1 experienced severe disease when exposed to Candida albicans (搜索). The findings suggest that the IL-1 immune pathway is critical in preventing Candida albicans from spreading around the body and causing life-threatening disease.
To investigate further, the researchers injected IL-1 (搜索)-deficient mice with a drug that removes neutrophils, a type of white blood cell that is among the first to respond to infections and helps fight threats such as bacteria and fungi. This approach allowed the team to mimic the weakened immune system seen in some immunocompromised patients. By then introducing Candida albicans (搜索) to the mouths of those mice, they for the first time observed the fungus spread throughout the body and cause fatal disease, confirming that IL-1 is critical in preventing disease from spreading.
Broader Implications for Fungal Defense
While the study focused specifically on Candida albicans (搜索), the researchers suggest the IL-1 (搜索) immune pathway may be a broader defense mechanism that helps keep fungi normally found in healthy microbiomes from spreading and causing fatal disease. Further research is needed to confirm whether this applies to other fungal species.
Dr. James S. Griffiths, Corresponding Author and Research Fellow at King's College London, explained the significance of the work: "Most people carry Candida albicans (搜索) harmlessly as part of the body's natural microbiome, but in immunocompromised patients it can spread throughout the body and become life-threatening. A major challenge has been understanding why a fungus that is normally harmless can suddenly spread beyond its natural niche and cause invasive disease. Our study identified the IL-1 (搜索) family as a critical early immune defense system that helps prevent this fungus from escaping the mouth and gut and spreading to multiple organs. We hope these findings will help identify patients at greatest risk of invasive fungal disease and provide a foundation for developing new ways to strengthen protective antifungal immunity."
Toward Personalized Prevention and Treatment
Understanding what causes fungi naturally present in our microbiomes, such as Candida albicans (搜索), to cause life-threatening disease could help spot at-risk patients earlier. The researchers suggest that, if confirmed in humans, the findings could lead to a test that identifies which immunocompromised patients have low levels of IL-1 (搜索) and are therefore at risk of Candida albicans escaping their microbiomes and causing disease before it happens.
While drugs such as antibiotics are currently used to treat life-threatening fungal diseases, more targeted therapies are needed that tackle the root cause of infection. The researchers suggest future clinical studies in humans could test whether drugs targeting IL-1 (搜索) could work as a personalized therapy for preventing life-threatening Candida albicans (搜索) infection.
Dr. Lea Lortal, co-author of the study and postdoctoral researcher in Mycology at The University of California, San Francisco (UCSF), underscored the unmet need: "Fungal infections are severely overlooked: they affect more than one billion people worldwide. Yet, there are still no clinically approved vaccines against any fungal pathogen, and our understanding of the immune mechanisms that protect us from fungal disease remains incomplete. What normally keeps fungi, such as Candida albicans (搜索), in check has remained a major unanswered question. In this study, we identified the IL-1 (搜索) family as a key early coordinator of the immune response that helps contain Candida before it can become invasive. Understanding how these protective responses are initiated is an important step toward developing better ways to prevent and treat invasive fungal infections."